Abiopharma

UTHR: Notification

New Form S-8 POS - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001310 Size: 30 KB

New Form DEF 14A - ADIAL PHARMACEUTICALS, INC. Filed: 2026-01-06 AccNo: 0001213900-26-001792 Size: 647 KB

Director SING GEORGE L 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

New Form 3 - Beyond Air, Inc. Filed: 2026-01-06 AccNo: 0001493152-26-000603 Size: 3 KB

Director Guarini Kathryn 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000003

(99% Neutral) Lifeward Ltd. (LFWD) Announces Regulatory Update

(99% Neutral) Adial Pharmaceuticals, Inc. (ADIL) Announces Executive Changes

PainReform Ltd. (PRFX) Files Form 6-K

Ede-Golightly James 🟢 acquired 90.0K shares (1 derivative) of Silence Therapeutics plc (SLN) at $2.05 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Munch Mark 🟡 adjusted position in 33.8K shares (3 derivative) of BRUKER CORP (BRKR) at $50.00 ($3.2M) Transaction Date: Jan 05, 2026 | Filing ID: 000002

MCINERNEY TIMOTHY 🟢 acquired 90.0K shares (1 derivative) of Silence Therapeutics plc (SLN) at $2.05 Transaction Date: Jan 02, 2026 | Filing ID: 000002

New Form S-8 POS - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001308 Size: 30 KB

Romano Steven J. 🟢 acquired 300.0K shares (1 derivative) of Silence Therapeutics plc (SLN) at $2.05 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Anaptys to Present at the 44th Annual J.P. Morgan Healthcare Conference